Fund Holdings — CAXTON CORP

Total Portfolio Value
$1.85M
Total Bought
$1.14M
Total Sold
$3.33M
Net Transaction
-$2.19M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
SPACE EXPLORATION TECHN CORP02,606+2,606044524.03%+445
ALPHABET INC(GOOG)0691+691024713.32%+247
VANGUARD INDEX FDS0339+339023312.58%+233
BLACKSTONE INC(BX)01,597+1,597018810.16%+188
BERKSHIRE HATHAWAY INC DEL727754+2734837720.35%+29
INHIBIKASE THERAPEUTICS INC(IKT)28,45328,453048583.12%+10
X4 PHARMACEUTICALS INC(XFOR)15,55715,557064733.92%+8
ALX ONCOLOGY HLDGS INC(ALXO)20,94620,946042432.34%+1
LEXEO THERAPEUTICS INC(LXEO)13,94316,962+3,01980794.26%-1
KYVERNA THERAPEUTICS INC(KYTX)18,77312,347-6,4261621105.94%-52
SPDR GOLD TR(GLD)7,6230-7,6233,2800—-3,280
Page 1 of 1
CAXTON CORP — 13F Holdings — Q2 2026 | TickerTrail